Beckman Coulter Inc – Beckman Coulter, Inc. JavaScript is required for this site. Please enable JavasScript for your browser. Change Password * Indicates required fields Change Email Address * Indicates required fields Confirm Country Selection Forgot Password * Indicates required fields Forgot your password? Please provide the email address and your last name associated... Read more
MILWAUKEE – June 9, 2017 – Demand for quality used parts has increased as hospitals and healthcare systems have become more sophisticated about medical equipment maintenance and management. Now more than 10,000 types of refurbished parts for GE Diagnostic Imaging equipment are available as GoldSeal parts from GE Healthcare. Hospital in-house service departments can find... Read more
Fourth generation Latent TB blood test combines breakthrough CD4/CD8 design for comprehensive immune response detection with the most flexible blood collection workflow Germantown, Maryland, and Hilden, Germany, June 8, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) the fourth generation of the market... Read more
High-throughput application of artus CMV QS-RGQ MDx Kit on QIAsymphony streamlines critical and frequently performed viral infection test for transplant patients Germantown, Maryland, and Hilden, Germany, June 6, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received premarket approval from the U.S. Food and Drug Administration (FDA) for its automated... Read more
Basel, 06 June 2017 Save the date: Roche Analyst Event on Diagnostics Division at AACC 2017 Tuesday, 1st August 2017 We are pleased to invite you to an analyst event on Tuesday, 1st August 2017 to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab... Read more
Download PDF Read more
NEW YORK and HILDEN, Germany, (June 3, 2017) – Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as predictive or prognostic tools for use with Bristol-Myers Squibb novel immuno-oncology (I-O) therapies in... Read more
Agreement Accelerates the Development of Tests to Help Assess Risk of Disease Recurrence in Women with Early-Stage Breast Cancer SANTA CLARA, Calif., June 2, 2017 Agilent Technologies Inc. (NYSE: A) and Agendia, Inc. today jointly announced an agreementto expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint... Read more
Industry leader brings to the forefront customer innovations for routine and advanced workflows that are changing the LC-MS landscape. June 01, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced that at ASMS 2017, it will highlight the cutting-edge innovations developed to power their most advanced LC-MS instrumentation and... Read more
NEW ORLEANS, June 1, 2017 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe 2017 meeting (www.asm.org), Bruker introduces major innovations for strain typing, hospital hygiene and infection control. The novel, bench-top IR Biotyper system for microbial strain typing is based on Fourier-Transform Infrared (FTIR) spectroscopy technology, and complements Bruker’s world-leading MALDI Biotyper mass... Read more